Century Therapeutics, Inc. (IPSC)
1.53
-0.08
(-4.97%)
USD |
NASDAQ |
Oct 02, 16:00
1.53
0.00 (0.00%)
After-Hours: 20:00
Century Therapeutics Net Income (Quarterly) : -34.55M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -34.55M |
| March 31, 2026 | -21.64M |
| December 31, 2025 | -19.17M |
| September 30, 2025 | -34.42M |
| June 30, 2025 | -32.54M |
| March 31, 2025 | 76.56M |
| December 31, 2024 | -36.07M |
| September 30, 2024 | -31.23M |
| June 30, 2024 | -31.21M |
| March 31, 2024 | -28.06M |
| December 31, 2023 | -39.40M |
| September 30, 2023 | -32.72M |
| June 30, 2023 | -33.29M |
| Date | Value |
|---|---|
| March 31, 2023 | -31.26M |
| December 31, 2022 | -31.68M |
| September 30, 2022 | -30.75M |
| June 30, 2022 | -30.99M |
| March 31, 2022 | -37.51M |
| December 31, 2021 | -28.19M |
| September 30, 2021 | -26.01M |
| June 30, 2021 | -23.27M |
| March 31, 2021 | -18.35M |
| December 31, 2020 | -15.53M |
| September 30, 2020 | -13.07M |
| June 30, 2020 | -15.30M |
| March 31, 2020 | -9.673M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | -17.80M |
| Exicure, Inc. | -1.121M |
| Absci Corp. | -33.21M |
| Celularity, Inc. | 0.675M |
| Cardio Diagnostics Holdings, Inc. | -1.502M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 34.55M |
| EPS Diluted (Quarterly) | -0.1679 |
| Enterprise Value | 195.19M |
| Earnings Yield | -58.62% |
| Normalized Earnings Yield | -55.87 |